Status:
COMPLETED
CPAP Therapy in Obstructive Sleep Apnea Patients With Pulmonary Hypertension
Lead Sponsor:
Zagazig University
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
All patients are newly diagnosed Obstructive Sleep Apnea patients performing full night polysmnographic sleep study, whose echocardiographic findings elucidate presence of pulmonary hypertension(PH). ...
Eligibility Criteria
Inclusion
- All patients are newly diagnosed Obstructive Sleep Apnea patients performing full night polysmnographic sleep study, whose echocardiographic findings elucidate presence of pulmonary hypertension(PH).
Exclusion
- Patients aged \< 18 years
- Patients with secondary PH, due to pulmonary diseases, or left ventricular heart diseases , or chronic thromboembolic disorders.
- Patients on long term oxygen therapy (LTOT).
- Patients with respiratory neuromuscular weaknesses or chest wall deformities.
- End-organ failure and malignancies
- Obesity hypoventilation syndrome.
Key Trial Info
Start Date :
October 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04769635
Start Date
October 15 2019
End Date
October 15 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmad Abbas
Zagazig, Sharqia Province, Egypt, 44519